Puma Biotech 'Is The Real Deal,' Overcomes Controversy With Positive FDA Panel Vote
May 25, 2017 at 11:21 AM EDT
Puma Biotechnology Inc (NASDAQ: PBYI) investors got some major vindication Wednesday when the FDA’s Oncologic Drugs Advisory ...